Drug intelligence / Profile preview

glucosamine + chondroitin sulfate + prednisolone

Development stage: Unknown
Lead developer: Pierre Fabre
Modality: Small Molecules
Administration: Oral, Intraarticular

Overview

This is a combination of glucosamine, chondroitin sulfate, and prednisolone. Glucosamine and chondroitin sulfate are natural components of articular cartilage commonly used as supplements for joint health. Glucosamine is an amino sugar that provides building blocks for cartilage synthesis, while chondroitin sulfate is a major component of the extracellular matrix. Prednisolone is a corticosteroid with anti-inflammatory properties. This combination may be used to manage osteoarthritis symptoms, potentially providing both symptom relief through anti-inflammatory action and supporting joint structure.

Targets

GR (Glucocorticoid receptor)

Beyond the preview

Go deeper on glucosamine + chondroitin sulfate + prednisolone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on glucosamine + chondroitin sulfate + prednisolone.

Explore the full profile